Quantum-Si Shares Slip After Next-Gen Proteomics Platforms Are Unveiled
Quantum-Si Shares Slip After Next-Gen Proteomics Platforms Are Unveiled
On the other hand, Quantum-Si will launch Proteus in the second half of 2026.Quantum-Si Inc (NASDAQ:QSI) shares tanked over 12.8% Thursday morning.
Quantum-Si公司（納斯達克股票代碼：QSI）的股價在週四早上下跌了12.8%。
The company plans to introduce Platinum Pro, an advanced version of its Platinum platform, in the first half of 2025. Platinum Pro will feature a streamlined workflow, reducing hands-on time and speeding up processing.
該公司計劃在2025年上半年推出Platinum Pro，這是其Platinum平台的高級版本。Platinum Pro將採用簡化工作流程，減少實際操作時間並加快處理速度。
It will support both local and cloud-based data analysis, and introduce a 'Pro Mode' for custom application development, offering a valuable tool for biopharmaceutical clients.
它將支持本地和基於雲的數據分析，並推出「Pro Mode」用於定製應用程序開發，爲生物製藥客戶提供一個有價值的工具。
On the other hand, Quantum-Si will launch Proteus in the second half of 2026.
另一方面，Quantum-Si將在2026年下半年推出Proteus。
Proteus is expected to offer advanced capabilities, including ultrasensitive detection of proteoforms, unbiased analysis of complex samples, and a new rapid sequencing chemistry that reduces run time to 90 minutes or less.
Proteus有望提供高級功能，包括對蛋白質形態的超靈敏檢測，對複雜樣本的無偏分析，以及一種新的快速測序化學方法，將運行時間縮短至90分鐘或更短。
The company expects Proteus to serve as the foundational platform for scaling sequencing output, progressing from tens of millions of reads per sample at launch to billions over time.
該公司期望Proteus能作爲擴展測序輸出的基礎平台，從推出時每個樣本數百萬次讀取到逐漸增長至數十億次讀取。
CEO Jeff Hawkins expects Proteus to "open broad new markets for diverse applications in protein analysis, driving increased revenue growth that will create significant value for our shareholders."
首席執行官傑夫·霍金斯期待Proteus能「爲蛋白質分析的各種應用開闢廣泛的新市場，推動營收增長，爲股東創造巨大價值。」
"With these technology advancements and partnerships in place, we believe we will be able to further extend our leadership position in next-generation protein sequencing while also extending into other areas of proteomics more generally."
「通過這些技術進展和夥伴關係，我們相信我們將能夠進一步鞏固在新一代蛋白質測序領域的領導地位，同時也拓展到更廣泛的蛋白質組學領域。」
To accelerate the development of Proteus and mitigate risks in the hardware platform delivery, Quantum-Si recently announced new partnerships and collaborations.
爲加快Proteus的開發並降低硬件平台交付風險，Quantum-Si最近宣佈了新的合作伙伴關係和合作。
Yesterday, Quantum-Si announced a collaboration with Nvidia to develop its new proteomics platform.
昨天，Quantum-Si宣佈與英偉達合作開發其新的蛋白質組學平台。
Also, the company entered into a distribution agreement with Avantor, as per which, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio in the U.S. and Canada, offering researchers across various market segments easier access to these innovative proteomics solutions.
此外，該公司與avantor簽訂了一項分銷協議，根據該協議，avantor將在美國和加拿大分發Quantum-Si的下一代蛋白質測序（NGPS）組合，在各種市場領域爲研究人員提供更便捷地接觸這些創新的蛋白質組學解決方案。
Price Action: Quantum-Si shares are down 12.88% at last check Thursday, trading around $1.21 a share.
價格走勢：Quantum-Si股價在上週四最後一次檢查時下跌了12.88%，交易價格約爲每股1.21美元。
Read Next:
閱讀下一篇：
- Uber Could Pick Up $10M Stake In Chinese Autonomous Driving Firm Pony AI's US IPO: Report
- 優步可能在中國自動駕駛公司Pony AI的美國上市中獲得1000萬美元的股份：報告
Image via Quantum-Si
圖片來自Quantum-Si
譯文內容由第三人軟體翻譯。
